Obinutuzumab Plus Bendamustine in Previously Untreated Patients With CLL: A Subgroup Analysis of the GREEN Study
Leukemia - United Kingdom
doi 10.1038/s41375-018-0146-5
Full Text
Open PDFAbstract
Available in full text
Date
April 27, 2018
Authors
Publisher
Springer Science and Business Media LLC